Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Arcus Biosciences (NYSE:RCUS), a clinical-stage biopharmaceutical company specializing in cancer therapeutics, has announced its participation in two major healthcare investor conferences in March 2025.
The company will attend the Leerink Global Healthcare Conference on March 12th, 2025, and the Barclays 27th Annual Global Healthcare Conference on March 13th, 2025. Both events will take place in Miami Beach, FL, featuring fireside chats and one-on-one meetings scheduled for 8:00 a.m. ET.
Investors can access live webcasts of these presentations through the Investors & Media section of www.arcusbio.com, with replay options available after the events.
Arcus Biosciences (NYSE:RCUS), un'azienda biofarmaceutica in fase clinica specializzata in terapie oncologiche, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a marzo 2025.
L'azienda parteciperà alla Leerink Global Healthcare Conference il 12 marzo 2025, e alla Barclays 27th Annual Global Healthcare Conference il 13 marzo 2025. Entrambi gli eventi si svolgeranno a Miami Beach, FL, con conversazioni informali e incontri individuali programmati per le 8:00 a.m. ET.
Gli investitori possono accedere alle dirette streaming di queste presentazioni attraverso la sezione Investitori & Media di www.arcusbio.com, con opzioni di riproduzione disponibili dopo gli eventi.
Arcus Biosciences (NYSE:RCUS), una empresa biofarmacéutica en etapa clínica especializada en terapias contra el cáncer, ha anunciado su participación en dos importantes conferencias para inversores en el sector de la salud en marzo de 2025.
La empresa asistirá a la Leerink Global Healthcare Conference el 12 de marzo de 2025, y a la Barclays 27th Annual Global Healthcare Conference el 13 de marzo de 2025. Ambos eventos se llevarán a cabo en Miami Beach, FL, con charlas informales y reuniones uno a uno programadas para las 8:00 a.m. ET.
Los inversores pueden acceder a las transmisiones en vivo de estas presentaciones a través de la sección de Inversores y Medios de www.arcusbio.com, con opciones de repetición disponibles después de los eventos.
Arcus Biosciences (NYSE:RCUS), 암 치료를 전문으로 하는 임상 단계의 생명공학 회사가 2025년 3월에 열리는 두 개의 주요 헬스케어 투자자 컨퍼런스에 참여한다고 발표했습니다.
회사는 2025년 3월 12일 Leerink Global Healthcare Conference와 2025년 3월 13일 Barclays 27th Annual Global Healthcare Conference에 참석할 예정입니다. 두 이벤트는 플로리다주 마이애미 비치에서 열리며, 8:00 a.m. ET에 진행되는 화상 대화 및 일대일 미팅이 예정되어 있습니다.
투자자들은 www.arcusbio.com의 투자자 및 미디어 섹션을 통해 이 프레젠테이션의 라이브 웹캐스트에 접근할 수 있으며, 이벤트 후에는 재생 옵션도 제공됩니다.
Arcus Biosciences (NYSE:RCUS), une entreprise biopharmaceutique en phase clinique spécialisée dans les thérapies contre le cancer, a annoncé sa participation à deux grandes conférences d'investisseurs dans le secteur de la santé en mars 2025.
L'entreprise assistera à la Leerink Global Healthcare Conference le 12 mars 2025 et à la Barclays 27th Annual Global Healthcare Conference le 13 mars 2025. Les deux événements se dérouleront à Miami Beach, FL, avec des discussions informelles et des réunions individuelles programmées à 8h00 ET.
Les investisseurs peuvent accéder aux diffusions en direct de ces présentations via la section Investisseurs & Médias de www.arcusbio.com, avec des options de rediffusion disponibles après les événements.
Arcus Biosciences (NYSE:RCUS), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Krebstherapien spezialisiert hat, hat seine Teilnahme an zwei wichtigen Gesundheitsinvestorenkonferenzen im März 2025 angekündigt.
Das Unternehmen wird am 12. März 2025 an der Leerink Global Healthcare Conference und am 13. März 2025 an der Barclays 27th Annual Global Healthcare Conference teilnehmen. Beide Veranstaltungen finden in Miami Beach, FL, statt und beinhalten informelle Gespräche sowie Einzelgespräche, die für 8:00 a.m. ET angesetzt sind.
Investoren können die Live-Übertragungen dieser Präsentationen über den Bereich Investoren & Medien auf www.arcusbio.com abrufen, mit Wiederholungsoptionen, die nach den Veranstaltungen verfügbar sind.
- None.
- None.
Leerink Global Healthcare Conference 2025
Date: Wednesday, March 12th, 2025
Location:
Format: Fireside chat & 1x1 meetings
Time: 8:00 a.m. ET
Barclays 27th Annual Global Healthcare Conference
Date: Thursday, March 13th, 2025
Location:
Format: Fireside chat & 1x1 meetings
Time: 8:00 a.m. ET
Live webcasts of the fireside chats and panel will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry collaborators, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, HIF-2a, CD73, A2a/A2b receptors, CD39 and AXL. For more information about Arcus Biosciences’s clinical and preclinical programs, please visit www.arcusbio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226469708/en/
Investor Inquiries
Pia Eaves (Banerjee)
Head of Investor Relations & Strategy
(617) 459-2006
peaves@arcusbio.com
Media Inquiries
Holli Kolkey
VP of Corporate Communications
(650) 922-1269
hkolkey@arcusbio.com
Maryam Bassiri
AD, Corporate Communications
(510) 406-8520
mbassiri@arcusbio.com
Source: Arcus Biosciences
FAQ
What investor conferences will Arcus Biosciences (RCUS) attend in March 2025?
How can investors access Arcus Biosciences (RCUS) conference presentations in March 2025?
What is the format of Arcus Biosciences (RCUS) participation in the March 2025 conferences?
Where will the Arcus Biosciences (RCUS) investor conferences be held in March 2025?
